Gut-brain axis: how the microbiome influences anxiety and depression.

By J. Foster, Karen‐Anne McVey Neufeld. Trends in Neurosciences, 2013

2,207 citations recorded by the source corpus.

Subfields: Molecular Biology, Physiology, Social Psychology

View Paper: https://www.semanticscholar.org/paper/7bf398378620a24a2bdf0953dc6033425c297fe2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

In Physiology

In Social Psychology

Citations in the corpus

Microbial genes, brain & behaviour – epigenetic regulation of the gut–brain axis (2014, background): “…Genes, Brain and Behavior (2014) 13: 69–86 T ab le 2: B io ch em ic al an d m ol ec ul ar al te ra tio ns w ith di ff er en tia lm ic ro bi ot a co m po si tio n Genes, Brain and Behavior (2014) 13: 69–86 73 a critical time window during adolescence (Clarke et al. 2013; Foster & Neufeld 2013).”
Gut Microbiome: Profound Implications for Diet and Disease (2019, background): “Moreover, increased levels of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) were detected in metabolite profiles of the brain hippocampus of KD-fed mice and were observed to be microbiota-dependent.”
Consumption of ultra-processed foods and health status: a systematic review and meta-analysis (2020, background): “In addition, it was also hypothesised that UPF can adversely affect health by modifying the gut microbiome in such away that it disturbs the energy balance and promotes the selection of microbes that promote inflammation-related diseases such as CVD and metabolic diseases and even depression(48,49).”
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems (2015, background): “In the meantime, emerging data support the role of microbiota in influencing anxiety and depressive-like behaviors [6,7] and, more recently, of dysbiosis in autism.”
Next-Generation Sequencing Technology: Current Trends and Advancements (2023, background): “Metagenomic studies have linked the gut microbiome to disorders affecting mental health [166], autoimmune diseases (rheumatoid arthritis) [167], and metabolic disorders (diabetes and obesity) [168], thus instrumental in evaluating the functional potential of the microbiome.”
Depression as a microglial disease. (2015, background): “For example, germ-free animals are hyper-responsive to stress, showing exaggerated HPA responses to restraint or novel environmental stressors [100], while probiotic treatment in animal models was shown to reduce depression-like behaviors and reverse the depression-like symptoms induced by maternal ”
Psychobiotics: a novel class of psychotropic. (2013, background): “The intestinal microbial balance may alter the regulation of inflammatory responses and in so doing may be involved in the modulation of mood and behavior (57,58) (Figure 1).”
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018, positive): “Emerging data support the role of microbiota in influencing anxiety and depressive-like behaviors (34).”
The Hologenome Concept: Human, Animal and Plant Microbiota (2014, background): “…Sudo et al. 2004; Neufeld et al. 2011) Human metabolites (Shaw 2010) and hormones (Bercik et al. 2011) Human and mice stress (Gonzalez et al. 2011; Foster and Neufeld 2013) Human autism (Cryan and Dinan 2012; Ramirez et al. 2013; Kang et al. 2013) Social behavior (Lombardo 2008; Lizé et al.…”
A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. (2015, methodology): “This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). q This work was supported by a research grant from The Netherlands Organization for Scientific Research (NWO) awarded to Lorenza S. Colzato (Vidi Grant: #452- 12-001).”
Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. (2016, background): “Probiotics may result in reduced depressive symptoms, as well as improved metabolic status, biomarkers of inflammation, and oxidative stress, through their effect on neuronal circuits and the central nervous system mediated by the microbiota-gutbrain axis [18] and through affecting gene expression [”